Nixon Peabody advises New York healthcare provider in strategic acquisition

July 14, 2015

Kaleida Health Deepens Urology and Cancer Care Services with Deal

Media Relations Director
Allison McClain

Albany, NY. Kaleida Health has increased its reach and number of patients served. In acquiring Western New York Urology Associates LLC and Cancer Care of WNY, two of the region’s largest private practice groups, Kaleida has strengthened its urology and cancer care services.

The combination adds 30 doctors and 350 employees to Kaleida’s network – largest in Western New York. The groups will still serve patients and refer doctors throughout the eight-county area from the same private office and hospital locations.

Western New York Urology, founded in 1996, has nine locations in Cheektowaga, Niagara, Orchard Park, Jamestown, Dunkirk, Corfu, Hamburg, Derby, and Springville. The practice has affiliation agreements with 23 hospitals and outpatient sites in the region and serves as a resident training site for the University at Buffalo School of Medicine & Biomedical Sciences.

Founded in 2008, Cancer Care of WNY specializes in treating breast, prostate and lung cancer, among others, and also offers expertise in urology and radiation oncology. It operates three locations in Cheektowaga, Jamestown and Cambria.

Nixon Peabody LLP advised Kaleida on the acquisition. The legal team was led by partners Peter Millock, Philip Rosenberg and Todd Tidgewell.

Back to top